Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00370240
Status:
COMPLETED
Last Update Posted:
2017-11-06
First Post:
2006-08-30
Brief Title:
Chlorhydrate of Ropivacaine and Breast Cancer Surgery
Sponsor:
Institut Curie
Organization:
Institut Curie
Study Overview
Official Title:
Efficacy of Infiltration of Chlorhydrate of Ropivacaine in the Prevention of Chronic Breast Pain After Surgery for Breast Cancer
Status:
COMPLETED
Status Verified Date:
2007-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to evaluate the effect of local anesthetic chlorhydrate of ropivacaine to prevent chronic pain after breast surgery for cancer
Detailed Description:
An estimated 20-65 of women treated with breast surgery for breast cancer experience chronic pain in the treated breast Patients will be randomize between infiltration with chlorhydrate of ropivacaine at the time of breast surgery for cancer versus placeboIntra-operative analgesia will be standardized as well as peri-operative pain management
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCT 2005-005691-32 | None | None | None |